Cargando…
Evaluation of methods to adjust for treatment switching in clinical trials
Autores principales: | Fox, Richard, Billingham, Lucinda, Abrams, Keith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287714/ http://dx.doi.org/10.1186/1745-6215-12-S1-A139 |
Ejemplares similares
-
Using meta-analysis of Phase II trials to predict Phase III trial results
por: Burke, Danielle, et al.
Publicado: (2013) -
Using a Bayesian approach with reverse philosophy to design clinical trials in rare diseases
por: Billingham, Lucinda, et al.
Publicado: (2013) -
Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia
por: Yap, Christina, et al.
Publicado: (2011) -
Implementation of adaptive dose-finding designs in two early phase haematological trials: clinical, operational, and methodological challenges
por: Yap, Christina, et al.
Publicado: (2013) -
Crossing survival curves: alternatives to the log-rank test
por: Bouliotis, George, et al.
Publicado: (2011)